WBP2 and breast cancer: Moreover, TCGA meta-analysis showed a downregulation of miR-23a in breast invasive carcinoma samples, reflecting that WBP2 oncogene is regulated by a potential tumor suppressor miR-23a in breast cancer (Fig. S4I).